Evidence map›Paper›PMID 26075187›Full record

ArticleFrontiers in cellular and infection microbiology2015

Epidemiology and characteristics of urinary tract infections in children and adolescents.

Rima H Hanna-Wakim, Soha T Ghanem, Mona W El Helou, Sarah A Khafaja, Rouba A Shaker, Sara A Hassan, Randa K Saad, Carine P Hedari, Rima W Khinkarly, Farah M Hajar and 6 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 3 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 3 syntheses or guidelines pooled it, 146 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Trial
  5. A new point-of-care test for the rapid detection of urinary tract infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Trial
  6. Review
  7. Article
  8. Extended-Spectrum β-Lactamase-ProducingAntibiotics (Basel, Switzerland) · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Rima H Hanna-WakimDivision of Pediatric Infectious Diseases, Department of Pediatrics and Adolescent Medicine, American University of Beirut Beirut, Lebanon ; Center for Infectious Diseases Research, American University of Beirut Beirut, Lebanon.
Soha T GhanemDepartment of Pediatrics, Makassed General Hospital Beirut, Lebanon.
Mona W El HelouCenter for Infectious Diseases Research, American University of Beirut Beirut, Lebanon.
Sarah A KhafajaCenter for Infectious Diseases Research, American University of Beirut Beirut, Lebanon.
Rouba A ShakerCenter for Infectious Diseases Research, American University of Beirut Beirut, Lebanon.
Sara A HassanCenter for Infectious Diseases Research, American University of Beirut Beirut, Lebanon.
Randa K SaadCenter for Infectious Diseases Research, American University of Beirut Beirut, Lebanon.
Carine P HedariCenter for Infectious Diseases Research, American University of Beirut Beirut, Lebanon.
Rima W KhinkarlyCenter for Infectious Diseases Research, American University of Beirut Beirut, Lebanon.
Farah M HajarDepartment of Pediatrics, Makassed General Hospital Beirut, Lebanon.
Marwan BakhashCenter for Infectious Diseases Research, American University of Beirut Beirut, Lebanon.
Dima El KarahCenter for Infectious Diseases Research, American University of Beirut Beirut, Lebanon.
Imad S AkelCenter for Infectious Diseases Research, American University of Beirut Beirut, Lebanon.
Mariam A RajabDepartment of Pediatrics, Makassed General Hospital Beirut, Lebanon.
Mireille KhouryCenter for Infectious Diseases Research, American University of Beirut Beirut, Lebanon.
Ghassan S DbaiboDivision of Pediatric Infectious Diseases, Department of Pediatrics and Adolescent Medicine, American University of Beirut Beirut, Lebanon ; Center for Infectious Diseases Research, American University of Beirut Beirut, Lebanon ; Division of Pediatric Infectious Diseases, Department of Pediatrics and Adolescent Medicine, American University of Beirut Beirut, Lebanon.
American University of Beirut · LBMakassed General Hospital · LB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUrinary tract infections (UTIs) are among the most common infections in the pediatric population. Over the last two decades, antibiotic resistance is increasing significantly as extended spectrum beta lactamase (ESBL) producing organisms are emerging. The aim of this study is to provide a comprehensive view of the epidemiologic characteristics of UTIs in hospitalized children, examine the risk factors of UTIs caused by ESBL-producing organisms, and determine the resistance patterns in the isolated organisms over the last 10 years.

methodsRetrospective chart review was conducted at two Lebanese medical centers. Subjects were identified by looking at the following ICD-9 discharge codes: "Urinary tract infection," "UTI," "Cystitis," and/or "Pyelonephritis." Children less than 18 years of age admitted for UTI between January 1st, 2001 and December 31st, 2011 were included. Cases whose urine culture result did not meet our definition for UTI were excluded. Chi-square, Fisher's exact test, and multivariate logistic regression were used to determine risk factors for ESBL. Linear regression analysis was used to determine resistance patterns.

resultsThe study included 675 cases with a median age of 16 months and female predominance of 77.7% (525 cases). Of the 584 cases caused by Escherichia coli or Klebsiella spp, 91 cases (15.5%) were found to be ESBL-producing organisms. Vesico-ureteral reflux and previous antibiotics use were found to be independent risk factors for ESBL-producing E. coli and Klebsiella spp. (p < 0.05). A significant linear increase in resistance to all generations of Cephalosporins (r (2) = 0.442) and Fluoroquinolones (r (2) = 0.698) was found.

conclusionThe recognition of risk factors for infection with ESBL-producing organisms and the observation of increasing overall resistance to antibiotics warrant further studies that might probably lead to new recommendations to guide management of UTIs and antibiotic use in children and adolescents.

Indexed as

beta-Lactam ResistanceAdolescentAnimalsBacteriabeta-LactamasesChildChild, PreschoolCohort StudiesFemaleHumansInfantInfant, NewbornMaleRetrospective StudiesRisk FactorsUrinary Tract Infectionsbeta-Lactamasesantibiotic resistancechildrenESBLrisk factorsurinary tract infection

Identifiers

PMID26075187
PMCPMC4443253
OpenAlexW1585063521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.